These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 352213)

  • 41. Failure of once-daily vancomycin for staphylococcal endocarditis.
    Marik PE
    Pharmacotherapy; 1998; 18(3):650-2. PubMed ID: 9620118
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evidence of less severe aortic valve destruction after treatment of experimental staphylococcal endocarditis with vancomycin and dexamethasone.
    Siaperas P; Pefanis A; Iliopoulos D; Katsarolis I; Kyroudi-Voulgari A; Donta I; Karayiannakos P; Giamarellou H
    Antimicrob Agents Chemother; 2001 Dec; 45(12):3531-7. PubMed ID: 11709335
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Aminoglycosides in the treatment of infectious endocarditis].
    Malinverni R
    Schweiz Med Wochenschr Suppl; 1996; 76():14S-20S. PubMed ID: 8677414
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Methicillin-resistant Staphylococcus aureus.
    Morris JG; Tenney JH
    Ann Intern Med; 1983 Aug; 99(2):283-4. PubMed ID: 6881798
    [No Abstract]   [Full Text] [Related]  

  • 45. The role of skin testing for penicillin allergy.
    Redelmeier DA; Sox HC
    Arch Intern Med; 1990 Sep; 150(9):1939-45. PubMed ID: 2203324
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antibiotic therapy of nonenterococcal streptococcal and staphylococcal endocarditis: current regimens and some future considerations.
    Karchmer AW
    J Antimicrob Chemother; 1988 Apr; 21 Suppl C():91-106. PubMed ID: 3290187
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antistaphylococcal β-Lactams versus Vancomycin for Treatment of Infective Endocarditis Due to Methicillin-Susceptible Coagulase-Negative Staphylococci: a Prospective Cohort Study from the International Collaboration on Endocarditis.
    Carugati M; Petti CA; Arnold C; Miro JM; Pericàs JM; Garcia de la Maria C; Kanafani Z; Durante-Mangoni E; Baddley J; Wray D; Klein JL; Delahaye F; Fernandez-Hidalgo N; Hannan MM; Murdoch D; Bayer A; Chu VH
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6341-9. PubMed ID: 27527083
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Endocarditis due to strain of Cardiobacterium hominis resistant to erythromycin and vancomycin.
    Prior RB; Spagna VA; Perkins RL
    Chest; 1979 Jan; 75(1):85-6. PubMed ID: 253635
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ceftaroline-Resistant, Daptomycin-Tolerant, and Heterogeneous Vancomycin-Intermediate Methicillin-Resistant Staphylococcus aureus Causing Infective Endocarditis.
    Nigo M; Diaz L; Carvajal LP; Tran TT; Rios R; Panesso D; Garavito JD; Miller WR; Wanger A; Weinstock G; Munita JM; Arias CA; Chambers HF
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28232309
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antimicrobial effects promoting biofilm formation and persistent disease: the role of a DNA-binding regulator, SarA, in staphylococcal endocarditis.
    Herrmann M
    J Infect Dis; 2014 Apr; 209(8):1153-5. PubMed ID: 24403558
    [No Abstract]   [Full Text] [Related]  

  • 51. Limitations of vancomycin in the management of resistant staphylococcal infections.
    Kollef MH
    Clin Infect Dis; 2007 Sep; 45 Suppl 3():S191-5. PubMed ID: 17712746
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Therapy for methicillin-resistant Staphylococcus aureus.
    Torres-Tortosa M; Caballero-Granado FJ; Canueto J
    N Engl J Med; 2006 Nov; 355(20):2153-4; author reply 2155. PubMed ID: 17120350
    [No Abstract]   [Full Text] [Related]  

  • 53. [Therapy and prevention of infectious endocarditis].
    Horstkotte D; Rosin H
    Schweiz Med Wochenschr; 1984 Nov; 114(45):1575-86. PubMed ID: 6515354
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
    Mohan SS; McDermott BP; Cunha BA
    Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vancomycin: treatment of staphylococcal septicemias and pseudomembranous colitis].
    Chevrel B
    Med Chir Dig; 1982; 11(3):217-21. PubMed ID: 7098605
    [No Abstract]   [Full Text] [Related]  

  • 56. Evaluation of antimicrobial agents in the rabbit model of endocarditis.
    Sande MA
    Rev Infect Dis; 1981; 3 suppl():S240-9. PubMed ID: 7342288
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.
    Fowler VG; Boucher HW; Corey GR; Abrutyn E; Karchmer AW; Rupp ME; Levine DP; Chambers HF; Tally FP; Vigliani GA; Cabell CH; Link AS; DeMeyer I; Filler SG; Zervos M; Cook P; Parsonnet J; Bernstein JM; Price CS; Forrest GN; Fätkenheuer G; Gareca M; Rehm SJ; Brodt HR; Tice A; Cosgrove SE;
    N Engl J Med; 2006 Aug; 355(7):653-65. PubMed ID: 16914701
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Correlates of therapeutic efficacy in experimental methicillin-resistant Staphylococcus aureus endocarditis.
    Bayer AS; Greenberg DP; Yih J
    Chemotherapy; 1988; 34(1):46-55. PubMed ID: 3162413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efficacy of Telavancin in a rabbit model of aortic valve endocarditis due to methicillin-resistant Staphylococcus aureus or vancomycin-intermediate Staphylococcus aureus.
    Madrigal AG; Basuino L; Chambers HF
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3163-5. PubMed ID: 16048918
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prosthetic valve endocarditis caused by Staphylococcus epidermidis. Development of rifampin resistance during vancomycin and rifampin therapy.
    Chamovitz B; Bryant RE; Gilbert DN; Hartstein AI
    JAMA; 1985 May; 253(19):2867-8. PubMed ID: 3989962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.